awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37854714-11891D38-9109-429C-A122-211C81AA7232
Q37854714-11891D38-9109-429C-A122-211C81AA7232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37854714-11891D38-9109-429C-A122-211C81AA7232
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphoma.
P2860
Q37854714-11891D38-9109-429C-A122-211C81AA7232
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37854714-11891D38-9109-429C-A122-211C81AA7232
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98eb61be1279d3ef6d01180fcb6fde0c034aa4af
P2860
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.